Chronic rhinosinusitis (CRS) significantly affects ophthalmologic health but remains largely manageable, according to a ...
The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback